Lv6
2655 积分 2023-11-18 加入
Design Strategies and Applications of ROS-Responsive Phenylborate Ester-Based Nanomedicine
4天前
已完结
Engineering Mild‐Photothermal Responsive and NO Donor Prussian Blue Nanozymes Using Mild Synthesis for Inflammation Regulation and Bacterial Eradication in Periodontal Disease
5天前
已完结
Crosstalk between SIRT1/Nrf2 signaling and NLRP3 inflammasome/pyroptosis as a mechanistic approach for the neuroprotective effect of linagliptin in Parkinson’s disease
8天前
已完结
AMP-Activated Protein Kinase Regulation of the NLRP3 Inflammasome during Aging
8天前
已完结
Injectable dual-gelling cell-laden composite hydrogels for bone tissue engineering
9天前
已完结
A Double Network Composite Hydrogel with Self-Regulating Cu2+/Luteolin Release and Mechanical Modulation for Enhanced Wound Healing
16天前
已完结
ROS Balance Autoregulating Core–Shell CeO2@ZIF-8/Au Nanoplatform for Wound Repair
16天前
已完结
Ultrathin ZIF‐8 Coating‐Reinforced Enzyme Nanoformulation Avoids Lysosomal Degradation for Senile Osteoporosis Therapy
16天前
已完结
Self‐Reinforced MOF‐Based Nanogel Alleviates Osteoarthritis by Long‐Acting Drug Release
17天前
已关闭
Self‐Reinforced MOF‐Based Nanogel Alleviates Osteoarthritis by Long‐Acting Drug Release
17天前
已完结
Expanding the solvent diversity and perovskite compatibility of SnO2 inks that are directly deposited on perovskite layers
6个月前
已采纳
Loss of SLC27A5 Activates Hepatic Stellate Cells and Promotes Liver Fibrosis via Unconjugated Cholic Acid
6个月前
已采纳
Moderate altitude exposure impacts host fasting blood glucose and serum metabolome by regulation of the intestinal flora
6个月前
已采纳
TRIB3–TRIM8 complex drives NAFLD progression by regulating HNF4α stability
6个月前
已采纳
Toxic red mud could be turned into ‘green’ steel
6个月前
已采纳
LGFF-YOLO: small object detection method of UAV images based on efficient local–global feature fusion
6个月前
已采纳
Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial
6个月前
已驳回
MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy
6个月前
已采纳
Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenario
6个月前
已驳回
Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab–ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trial
6个月前
已采纳
皖公网安备34019202002308
